These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7516367)

  • 21. Epidemiology of benign prostatic hyperplasia.
    O'Leary MP
    Br J Urol; 1995 Jul; 76 Suppl 1():1-3. PubMed ID: 7544209
    [No Abstract]   [Full Text] [Related]  

  • 22. [Benign prostatic hypertrophy].
    Ogawa Y
    Nihon Rinsho; 1993 Jan; 51 Suppl():468-77. PubMed ID: 7681488
    [No Abstract]   [Full Text] [Related]  

  • 23. [The surgical treatment of prostatic hypertrophy].
    Esch W
    Z Urol Nephrol; 1966 Apr; 59(4):279-84. PubMed ID: 4168842
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prostatic cryotherapy].
    Trinquet H
    J Urol Nephrol (Paris); 1977; 83 Suppl 2():418-20. PubMed ID: 83383
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.
    Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW
    Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
    Galić J; Simunović D
    Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of various factors in the occurrence of prostatic cancer].
    Chaklin AV; Plotnikov SV
    Urol Nefrol (Mosk); 1984; (4):46-51. PubMed ID: 6206634
    [No Abstract]   [Full Text] [Related]  

  • 28. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Considerations on operative risk in prostatic hypertrophy].
    Anfossi F; Veronesi G
    Acta Gerontol (Milano); 1964; 14(3):148-57. PubMed ID: 4160292
    [No Abstract]   [Full Text] [Related]  

  • 31. Signs and symptoms of benign prostatic hyperplasia in men screened for prostatic carcinoma.
    Bosch JL; Niemer AQ; Kirkels WJ; Schröder FH
    Prog Clin Biol Res; 1994; 386():97-107. PubMed ID: 7528432
    [No Abstract]   [Full Text] [Related]  

  • 32. The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey.
    Kaplan SA
    J Urol; 2005 Jun; 173(6):2058. PubMed ID: 15879832
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
    Gualdi GF; Polettini E; Casciani E
    Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation and treatment of BPH, 2002.
    Stein B
    Med Health R I; 2002 May; 85(5):153-5. PubMed ID: 12048748
    [No Abstract]   [Full Text] [Related]  

  • 35. The frequency of benign prostate hypertrophy in Calabar.
    Umezurike BI; Ekanem TB; Eluwa MA; Etta KK; Udo-Affah GA; Aligwekwe AU
    Niger Postgrad Med J; 2006 Sep; 13(3):236-9. PubMed ID: 17278305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia.
    Yoong HF; Sundaram MB; Aida Z
    Med J Malaysia; 2005 Aug; 60(3):294-6. PubMed ID: 16379182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign prostatic hyperplasia presenting with renal failure--what is the role for transurethral resection of the prostate (TURP)?
    Thomas AZ; Thomas AA; Conlon P; Hickey D; Little DM
    Ir Med J; 2009 Feb; 102(2):43-4. PubMed ID: 19405316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.